DMU-212, a resveratrol analog, is primarily studied for its potential anticancer properties. It has shown promise in inhibiting the growth of various cancer cells, including breast, prostate, and colon cancers. The compound works by inducing apoptosis, or programmed cell death, in cancer cells while sparing normal cells. Additionally, DMU-212 has been explored for its anti-inflammatory and antioxidant effects, which could contribute to its therapeutic potential in chronic diseases. Research is ongoing to further understand its mechanisms and optimize its use in cancer treatment and prevention.